World Equity Group’s AbbVie ABBV Stock Holding History

World Equity Group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.01M	Buy	7,975 +96	+1%	+$20.7K	0.45%	45
2026 Q1	$1.71M	Buy	7,879 +91	+1%	+$20.2K	0.44%	44
2025 Q4	$1.78M	Sell	7,788 -1,124	-13%	-$256K	0.5%	38
2025 Q3	$2.06M	Buy	8,912 +497	+6%	+$101K	0.47%	44
2025 Q2	$1.56M	Sell	8,415 -351	-4%	-$65.2K	0.43%	50
2025 Q1	$1.82M	Sell	8,766 -1,559	-15%	-$303K	0.52%	43
2024 Q4	$1.84M	Buy	10,325 +2,625	+34%	+$483K	0.39%	51
2024 Q3	$1.52M	Sell	7,700 -396	-5%	-$73.9K	0.55%	42
2024 Q2	$1.39M	Buy	8,096 +409	+5%	+$67.8K	0.41%	69
2024 Q1	$1.4M	Sell	7,687 -1,063	-12%	-$183K	0.29%	91
2023 Q4	$1.36M	Buy	8,750 +286	+3%	+$41.7K	0.27%	90
2023 Q3	$1.27M	Sell	8,464 -321	-4%	-$47.1K	0.26%	97
2023 Q2	$1.18M	Sell	8,785 -9,349	-52%	-$1.37M	0.35%	79
2023 Q1	$1.13M	Buy	18,134 +5,119	+39%	+$783K	0.17%	150
2022 Q4	$2.1M	Buy	13,015 +319	+3%	+$48.9K	0.5%	57
2022 Q3	$1.7M	Sell	12,696 -1,829	-13%	-$262K	0.43%	59
2022 Q2	$2.22M	Sell	14,525 -274	-2%	-$41.9K	0.56%	45
2022 Q1	$2.4M	Buy	+14,799	New	+$2.15M	0.52%	47

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

World Equity Group's ABBV Position: Q2 2026 in Review

World Equity Group increased its AbbVie (ABBV) stake by 1.2% in Q2 2026, buying an estimated $20.7K and bringing the position to 7,975 shares worth $2.01M. The position accounts for 0.45% of the portfolio, ranked #45.

World Equity Group first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.4M in Q1 2022. 1,010 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

World Equity Group held 7,975 shares of AbbVie worth $2.01M as of Q2 2026.
World Equity Group bought 96 AbbVie shares in Q2 2026, an estimated $20.7K.
AbbVie made up 0.45% of World Equity Group's portfolio in Q2 2026, its #45 holding.
World Equity Group first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
World Equity Group's AbbVie position peaked at $2.4M in Q1 2022.
1,010 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on World Equity Group's 13F filing for Q2 2026, filed 9 Jul 2026.